S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Obama’s 2024 Confession (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Obama’s 2024 Confession (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Recession risks are fading, business economists say, but political tensions pose threat to economy
New Trump Bombshell (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Stock market today: World shares mostly higher after S&P 500 tops 5,000
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Obama’s 2024 Confession (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Obama’s 2024 Confession (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Recession risks are fading, business economists say, but political tensions pose threat to economy
New Trump Bombshell (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Stock market today: World shares mostly higher after S&P 500 tops 5,000
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Obama’s 2024 Confession (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Obama’s 2024 Confession (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Recession risks are fading, business economists say, but political tensions pose threat to economy
New Trump Bombshell (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Stock market today: World shares mostly higher after S&P 500 tops 5,000
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Obama’s 2024 Confession (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Obama’s 2024 Confession (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Recession risks are fading, business economists say, but political tensions pose threat to economy
New Trump Bombshell (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Stock market today: World shares mostly higher after S&P 500 tops 5,000

Jasper Therapeutics (JSPRW) SEC Filings & 10K Form

$0.20
+0.01 (+6.84%)
(As of 02/8/2024 09:09 PM ET)

Recent Jasper Therapeutics SEC Filings

DateFilerForm TypeView
02/09/2024
7:36 PM
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Velan Capital Investment Management LP (Filed by)
Form SC 13D/A
02/09/2024
7:40 PM
Avego Healthcare Capital Holdings, LLC (Reporting)
Avego Healthcare Capital, L.P. (Reporting)
Avego Management LLC (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Morgan Adam (Reporting)
Velan Capital Holdings LLC (Reporting)
Velan Capital Investment Management LP (Reporting)
Velan Capital Management LLC (Reporting)
Velan Capital Master Fund LP (Reporting)
VENKATARAMAN BALAJI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
8:07 AM
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2024
8:15 AM
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
Form SC 13G/A
02/02/2024
8:50 AM
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
Form SC 13G/A
01/04/2024
5:04 AM
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2024
7:05 AM
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
5:06 AM
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2023
7:14 PM
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
WIGGANS THOMAS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
4:11 PM
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Form DEF 14A
11/09/2023
3:01 PM
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Form PRE 14A
11/09/2023
8:18 AM
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2023
7:05 AM
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
4:58 PM
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
WIGGANS THOMAS G (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/02/2023
5:00 PM
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
WIGGANS THOMAS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2023
7:00 AM
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/20/2023
5:04 AM
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2023
5:55 PM
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Lis William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/13/2023
5:56 PM
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Lis William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2023
5:57 PM
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
MARTELL RON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2023
5:58 PM
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Mahal Jeetinder Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
10:15 AM
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
Form SC 13G
10/10/2023
6:00 AM
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2023
5:19 AM
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2023
3:14 PM
CROSS HERB (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/26/2023
3:16 PM
CROSS HERB (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2023
7:00 AM
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2023
7:05 AM
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2023
3:05 PM
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2023
3:06 PM
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/20/2023
8:47 PM
Brun Scott C. (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/20/2023
8:48 PM
Brun Scott C. (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
8:09 PM
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Mahal Jeetinder Singh (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2023
7:45 PM
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Tucker Edwin Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
7:54 PM
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Mahal Jeetinder Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
7:45 PM
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Tucker Edwin Jonathan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/08/2023
5:41 PM
French Anna Louise (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
5:42 PM
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Lis William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
5:42 PM
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Nolet Chris (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
5:43 PM
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Shizuru Judith Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
5:43 PM
EMSTER KURT VON (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
5:44 PM
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
5:44 PM
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Kapoor Vishal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2023
11:15 PM
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Form EFFECT
04/14/2023
3:17 PM
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
MARTELL RON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2023
3:19 PM
EMSTER KURT VON (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2023
3:19 PM
French Anna Louise (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2023
3:25 PM
French Anna Louise (Reporting)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/13/2023
4:20 PM
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Lis William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/13/2023
1:33 PM
EMSTER KURT VON (Reporting)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/11/2023
6:55 PM
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
MCDADE MARK (Reporting)
Qiming U.S. Healthcare Fund II, L.P. (Reporting)
Qiming U.S. Healthcare GP II, LLC (Reporting)
RIESCHEL GARY E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2023
3:01 PM
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Form PRE 14A
03/20/2023
4:59 PM
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
MARTELL RON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2023
5:00 PM
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Mahal Jeetinder Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2023
7:35 PM
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Kapoor Vishal (Reporting)
Form 3/A
02/17/2023
7:30 AM
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Kapoor Vishal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2023
7:20 AM
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/17/2023
7:25 AM
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Kapoor Vishal (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/13/2023
3:49 PM
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
ROCHE FINANCE LTD (Filed by)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:JSPRW) was last updated on 2/12/2024 by MarketBeat.com Staff

My Account -